Levetiracetam monotherapy during pregnancy: a case series

Epilepsy Behav. 2003 Aug;4(4):447-8. doi: 10.1016/s1525-5050(03)00122-7.

Abstract

The safety and efficacy of novel anticonvulsants during pregnancy in women with epilepsy are not well established. Although there are a variety of pregnancy registries accruing data on various outcomes, health care professionals managing women of childbearing age are interested in any information that may assist with clinical decisions. This case series summarizes the clinical outcomes of three women with epilepsy, all of whom took levetiracetam as monotherapy during pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Drug-Induced / epidemiology
  • Abnormalities, Drug-Induced / etiology
  • Anticonvulsants / adverse effects
  • Anticonvulsants / therapeutic use*
  • Epilepsy / drug therapy*
  • Female
  • Humans
  • Infant, Newborn
  • Levetiracetam
  • Piracetam / adverse effects
  • Piracetam / analogs & derivatives*
  • Piracetam / therapeutic use*
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Pregnancy Outcome
  • Prenatal Exposure Delayed Effects
  • Treatment Outcome

Substances

  • Anticonvulsants
  • Levetiracetam
  • Piracetam